Medtronic Inc. has launched a new handpiece for its sinus irrigation system that’s designed to make it easier for physicians to access hard-to-reach areas of the frontal sinus.
The new Frontal Handpiece works with Medtronic’s Hydrodebrider System, which is an endoscopic system that’s used to remove bacteria from the sinuses, according to a statement from Medtronic.
The frontal sinuses have “narrow, complex anatomical features” that necessitate using special devices for irrigation, said Bryan Jones, associate product manager for Rhinology in Medtronic’s Ear, Nose and Throat division.
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
Each handpiece delivers a rotating spray of pressurized saline to irrigate and remove bacteria from the sinuses.
Chronic sinusitis is defined as an inflammation of the tissues around the nasal passages for at least 12 consecutive weeks, and is a disease that affects about 30 million U.S. adults, according to Medtronic.
Sinusitis treatment has been a hot market recently. Last December, Johnson & Johnson acquired Acclarent Inc., a company that developed a balloon catheter system to treat sinusitis, for $785 million. Maple Grove, Minn.-based Entellus Medical, which is working on a similar balloon catheter that’s inserted through an incision in the upper lip, recently raised $30 million. Entellus estimates the worldwide market for chronic sinusitis treatments at more than $1 billion.
Chronic sinusitis can be treated in a number of ways, including the use of nasal spray and antibiotics. When other methods fail, endoscopic surgery may be necessary to remove obstructions and diseased tissue.
5 High-Impact Tax Strategies Every Physician Should Use in 2026 to Reduce Their Tax Bill
AI-native tax firm Gelt combines top human tax experts with AI to help physicians and healthcare practices use data-driven tax strategies to lower liabilities, improve profitability, and future-proof their finances.